000 | 01122 a2200313 4500 | ||
---|---|---|---|
005 | 20250516115831.0 | ||
264 | 0 | _c20121101 | |
008 | 201211s 0 0 swe d | ||
022 | _a0023-7205 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAlshakarchi, Jinan | |
245 | 0 | 0 |
_a[HAS-BLED shows bleeding risk in ischemic stroke and atrial fibrillation. But adjustments are needed for safer assessment, according to quality study]. _h[electronic resource] |
260 |
_bLakartidningen _c |
||
300 |
_a1670-2 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
650 | 0 | 4 |
_aAtrial Fibrillation _xcomplications |
650 | 0 | 4 |
_aDrug Prescriptions _xstatistics & numerical data |
650 | 0 | 4 |
_aHemorrhage _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aRisk Assessment _xmethods |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aStroke _xdrug therapy |
650 | 0 | 4 |
_aSweden _xepidemiology |
650 | 0 | 4 |
_aThromboembolism _xdrug therapy |
700 | 1 | _aTerént, Andreas | |
773 | 0 |
_tLakartidningen _gvol. 109 _gno. 38 _gp. 1670-2 |
|
999 |
_c22209267 _d22209267 |